News
DNPUF
10.50
NaN%
--
Jefferies Keeps Their Buy Rating on Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 15h ago
Sumitomo Pharma to Book Extraordinary Income From Retirement Benefit Trust Asset Return
TipRanks · 08/28 10:21
Sumitomo Pharma Rejects Short-Seller Report, Defends AMCHEPRY Approval
TipRanks · 08/11 23:52
Sumitomo Pharma Rebuts Short-Seller Report, Defends Accounting Practices
TipRanks · 08/07 04:29
Jefferies Keeps Their Buy Rating on Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 08/04 14:13
Sumitomo Pharma Rejects Allegations in Gotham City Research Report
TipRanks · 08/04 05:52
Sumitomo Pharma Q1 FY2026 Profit Surges Despite Higher Costs
TipRanks · 07/31 07:08
Sumitomo Pharma Flags Uncertainty in Q1 FY2026 Outlook
TipRanks · 07/31 07:08
Sumitomo Pharma Affirms Independence as Sumitomo Chemical Retains Control
TipRanks · 06/25 07:03
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sumitomo Dainippon Pharma Co (OtherDNPUF) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)
TipRanks · 05/26 00:50
Sumitomo Pharma Cancels Planned Third-Party Share Allotment After Allottee Declines
TipRanks · 05/22 07:52
Sumitomo Pharma Co., Ltd. GAAP EPS of ¥268.99, revenue of ¥453.29B
Seeking Alpha · 05/13 17:41
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
TipRanks · 05/13 04:33
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
TipRanks · 05/13 04:33
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
TipRanks · 04/27 02:52
Sumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
TipRanks · 04/20 08:53
Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
TipRanks · 04/08 07:37
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
TipRanks · 04/08 07:37
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
TipRanks · 03/25 07:02
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
TipRanks · 03/06 00:22
More
Webull provides a variety of real-time DNPUF stock news. You can receive the latest news about DAI Nippon Pharm through multiple platforms. This information may help you make smarter investment decisions.
About DNPUF
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.